GB202009820D0 - Chemical compounds derived from Yi traditional medicine, Yunnan bat study, & brown algae for use in therapy or prophylaxis for the medical condition COVID-19 - Google Patents

Chemical compounds derived from Yi traditional medicine, Yunnan bat study, & brown algae for use in therapy or prophylaxis for the medical condition COVID-19

Info

Publication number
GB202009820D0
GB202009820D0 GBGB2009820.8A GB202009820A GB202009820D0 GB 202009820 D0 GB202009820 D0 GB 202009820D0 GB 202009820 A GB202009820 A GB 202009820A GB 202009820 D0 GB202009820 D0 GB 202009820D0
Authority
GB
United Kingdom
Prior art keywords
covid
yunnan
bat
prophylaxis
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2009820.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sheridan Richard John
Original Assignee
Sheridan Richard John
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sheridan Richard John filed Critical Sheridan Richard John
Priority to GBGB2009820.8A priority Critical patent/GB202009820D0/en
Publication of GB202009820D0 publication Critical patent/GB202009820D0/en
Ceased legal-status Critical Current

Links

GBGB2009820.8A 2020-06-26 2020-06-26 Chemical compounds derived from Yi traditional medicine, Yunnan bat study, & brown algae for use in therapy or prophylaxis for the medical condition COVID-19 Ceased GB202009820D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2009820.8A GB202009820D0 (en) 2020-06-26 2020-06-26 Chemical compounds derived from Yi traditional medicine, Yunnan bat study, & brown algae for use in therapy or prophylaxis for the medical condition COVID-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2009820.8A GB202009820D0 (en) 2020-06-26 2020-06-26 Chemical compounds derived from Yi traditional medicine, Yunnan bat study, & brown algae for use in therapy or prophylaxis for the medical condition COVID-19

Publications (1)

Publication Number Publication Date
GB202009820D0 true GB202009820D0 (en) 2020-08-12

Family

ID=71949727

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2009820.8A Ceased GB202009820D0 (en) 2020-06-26 2020-06-26 Chemical compounds derived from Yi traditional medicine, Yunnan bat study, & brown algae for use in therapy or prophylaxis for the medical condition COVID-19

Country Status (1)

Country Link
GB (1) GB202009820D0 (en)

Similar Documents

Publication Publication Date Title
PH12016501394A1 (en) Compounds for treating patients with ros1 mutant cancer cells
AU2015205914B2 (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
WO2015148415A3 (en) Use of the fl118 core chemical structure platform to generate fl118 derivatives for treatment of human disease
MX2017012393A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use.
NZ713621A (en) Compounds and methods of treating infections
MX340533B (en) 1,6- diazabicyclo [3,2,1] octan- 7 - one derivatives and their use in the treatment of bacterial infections.
MX2016015248A (en) Imidazo[1,2-a]pyrazin-1yl-benzamide compounds for treating spinal muscular atrophy.
MX2014008446A (en) Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines.
SG10201906400SA (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
IL202351A (en) Substituted (2-oxo-1,3-oxazolidin-5-yl)methyl-thiophene-2-carboxamides, process for preparing same and use thereof for preparing medicaments for the treatment and/or prophylaxis of diseases
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2016016388A (en) Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
FR2996838B1 (en) PROCESS FOR THE PREPARATION OF A TITANIUM AND NIOBIUM MIXED OXIDE BY SOLVOTHERMAL TREATMENT; ELECTRODE AND LITHIUM ACCUMULATOR COMPRISING SAID MIXED OXIDE
NZ745185A (en) 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
NZ603442A (en) Treatment of proliferative diseases
WO2016176675A3 (en) Patient treatment via teratogenic pharmaceutical compounds
MX2013007055A (en) Sanglifehrin derivatives and methods for their production.
TN2016000497A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
GB202009820D0 (en) Chemical compounds derived from Yi traditional medicine, Yunnan bat study, & brown algae for use in therapy or prophylaxis for the medical condition COVID-19
EA201590350A1 (en) PEPTIDE COMBINATIONS WITH A CYCLIZED MAIN CHAIN
WO2016066722A3 (en) Bacteriophage combinations for human or animal therapy
GB202008314D0 (en) Chemical compounds for use in the therapy or prohylaxis for the medical condition COVID-19
NZ631362A (en) Arry-520 for use in treating cancer in a patient with low aag

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)